Cargando…
High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients
BACKGROUND: Hepatocellular carcinoma (HCC) adopts several tumor immune escape mechanisms; therefore, it has the potential to be targeted by immunotherapy. Indoleamine 2, 3-dioxygenase (IDO) is an immunosuppressive enzyme that has been observed to be overexpressed in HCC patients with poor prognoses....
Autores principales: | Asghar, Kashif, Rana, Iftikhar Ali, Abu Bakar, Muhammad, Hasham, Kinza, Tahseen, Muhammad, Bilal, Sundus, Mehmood, Shafqat, Farooq, Asim, Siddique, Kashif, Loya, Asif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495885/ https://www.ncbi.nlm.nih.gov/pubmed/37247278 http://dx.doi.org/10.31557/APJCP.2023.24.5.1591 |
Ejemplares similares
-
Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan
por: Asghar, Kashif, et al.
Publicado: (2019) -
Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan
por: Asghar, Kashif, et al.
Publicado: (2019) -
Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients
por: Asghar, Kashif, et al.
Publicado: (2020) -
Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase
por: Asghar, Kashif, et al.
Publicado: (2021) -
Indoleamine 2,3-Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
por: Farooq, Asim, et al.
Publicado: (2023)